Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
6094873 | Gastroenterology | 2013 | 12 Pages |
Abstract
Based on studies of human PDAC samples and KPC mice, activated PSCs appear to reduce migration of CD8+ T cells to juxtatumoral stromal compartments, preventing their access to cancer cells. Deregulated signaling by activated PSCs could prevent an effective antitumor immune response.
Keywords
PBDTMAMDSCPSCTregatRAPancreatic ductal adenocarcinomaPDAC یا pancreatic ductal adenocarcinomaall-trans retinoic acidAntitumor immunityPancreatic cancerRegulatory T cellpancreatic stellate cellmyeloid-derived suppressor cellMouse modelImmune regulationTissue microarrayAmpullary carcinomaCholangiocarcinoma
Related Topics
Health Sciences
Medicine and Dentistry
Gastroenterology
Authors
Abasi Ene-Obong, Andrew J. Clear, Jennifer Watt, Jun Wang, Rewas Fatah, John C. Riches, John F. Marshall, Joanne Chin-Aleong, Claude Chelala, John G. Gribben, Alan G. Ramsay, Hemant M. Kocher,